Get With the Guidelines Atrial Fibrillation Registry

Get With the Guidelines-Atrial Fibrillation

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06245187

Acronym

GWTG-AF

Enrollment

17198

Registered

2024-02-07

Start date

2013-01-31

Completion date

2040-01-31

Last updated

2025-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation, Atrial Flutter

Brief summary

Get With The Guidelines-Atrial Fibrillation is designed to assist hospital care teams in consistently providing the latest evidence-based treatment for their AFib patients. At the same time, it offers a means of monitoring the quality of AFib care in U.S. hospitals and building a database for continued research and further quality improvement.

Detailed description

Get With The Guidelines-Atrial Fibrillation was initiated in 2013 with over 88 U.S. hospitals participating is designed to assist hospital care teams in consistently providing the latest evidence-based treatment for their AFib patients. At the same time, it offers a means of monitoring the quality of AFib care in U.S. hospitals and building a database for continued research and further quality improvement. Achievement measures tracked through Get With The Guidelines-Atrial Fibrillation: 1. ACEI/ARB at discharge for LVSD 2. Assessment of thromboembolic risk factors 3. Beta Blocker at discharge 4. Discharged on FDA-approved anticoagulation therapy 5. PT/INR planned follow-up 6. Statin at discharge in AF patients with CAD, CVA/TIA or PVD. Quality measures tracked through Get With The Guidelines-Atrial Fibrillation: 1. Aldosterone antagonist at discharge 2. Atrial fibrillation patient education 3. Anticoagulation therapy education 4. CHA2DS2-VASC reported 5. Discharge heart rate \<110bpm 6. Smoking cessation 7. Warfarin at discharge for valvular atrial fibrillation Additional measures collected by Get With The Guidelines-Atrial Fibrillation can be viewed at: http://www.heart.org/idc/groups/heart-public/@private/@wcm/@hcm/@gwtg/documents/downloadable/ucm\_451183.pdf

Interventions

OTHERGWTG Atrial Fibrillation program

Evidence based recommended therapies and counseling prior to hospital discharge.

Study design

Observational model

COHORT

Time perspective

OTHER

Eligibility

Sex/Gender

ALL

Age

18 Years to 125 Years

Healthy volunteers

Yes

Inclusion criteria

* Patients hospitalized with nonvalvular Atrial Fibrillation or Atrial Flutter

Exclusion criteria

* Patients who do not have nonvalvular Atrial Fibrillation or Atrial Flutter * Patients under 18 years of age * Patients not admitted as inpatients. * Patients on comfort care only * Patients discharged to hospice.

Design outcomes

Primary

Measure	Time frame	Description
Cardiac Tamponade and/or Pericardiocentesis Following Ablation	30 days	Percent of patients with cardiac tamponade and/or pericardiocentesis occurring within 30 days following ablation procedure.

Countries

United States

Contacts

Primary ContactAmy Bennett, JD

amy.bennett@heart.org214-706-2237

Backup ContactChristine Rutan

Christine.Rutan@heart.org

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026